rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-8-30
|
pubmed:abstractText |
Adverse drug reactions may be manifested through changes in microvascular function (e.g. angioedema) or by subtle modification of the mechanisms controlling vascular tone, such as flow-mediated dilatation. Until now the early detection of such adverse drug reactions has been hampered by the lack of a predictive in vitro model. This in vitro model can be utilised to test potential effect of drugs on the normal responses of the vascular system.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1873-488X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
40-6
|
pubmed:meshHeading |
pubmed-meshheading:20435153-15-Hydroxy-11 alpha,9...,
pubmed-meshheading:20435153-Acetylcholine,
pubmed-meshheading:20435153-Arteries,
pubmed-meshheading:20435153-Capillary Permeability,
pubmed-meshheading:20435153-Enzyme Inhibitors,
pubmed-meshheading:20435153-Hemostatics,
pubmed-meshheading:20435153-Humans,
pubmed-meshheading:20435153-Ivermectin,
pubmed-meshheading:20435153-Microvessels,
pubmed-meshheading:20435153-Muscle, Smooth, Vascular,
pubmed-meshheading:20435153-Myography,
pubmed-meshheading:20435153-NG-Nitroarginine Methyl Ester,
pubmed-meshheading:20435153-Pressure,
pubmed-meshheading:20435153-Thrombin,
pubmed-meshheading:20435153-Vasoconstrictor Agents,
pubmed-meshheading:20435153-Vasodilation,
pubmed-meshheading:20435153-Vasodilator Agents
|
pubmed:articleTitle |
A novel system for the investigation of microvascular dysfunction including vascular permeability and flow-mediated dilatation in pressurised human arteries.
|
pubmed:affiliation |
Biopta Ltd, Weipers Centre, Garscube Estate, Bearsden Road, Glasgow, G61 1QH, UK.
|
pubmed:publicationType |
Journal Article
|